Women at higher risk for vision impairment

Article

More women than men have the four leading eye diseases in the U.S.: age-related macular degeneration, cataracts, glaucoma, and diabetic retinopathy.

Chicago-Of the 4.1 million Americans age 40 and older who are visually impaired or blind, 2.6 million are women. And, results of a recent study by Prevent Blindness America (PBA) show more women than men have age-related macular degeneration, cataracts, glaucoma, and diabetic retinopathy-the four leading eye diseases in the U.S.

PBA has designated April as Women’s Eye Health and Safety Month in an effort to educate women about the steps they can take today to help preserve vision in the future.

“The first thing every woman should do, especially those ages 40 and older, is get a dilated eye exam," said Hugh R. Parry, president and chief executive officer, PBA. "Through early detection and treatment, vision loss can be lessened.”

PBA also recommends a healthy diet, quitting smoking, taking supplements (as approved by a medical professional), consistently wearing UV-blocking sunglasses with a brimmed hat outdoors, and learning of any family history of eye disease.

For more information on women’s eye health, visit www.preventblindness.org.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Dana Shannon, OD, FAAO, shares pearls on spotting red flags in need of referral and enhancing patient care with follow-up compliance.
Dana Shannon, OD, FAAO, detailed a lecture she gave at the NOA Midwestern Symposium earlier this month.
CRU 2025 provided the latest insights regarding glaucoma, dry eye disease, retina, myopia, neurotrophic keratitis, and keratoconus.
Melissa Tawa, OD, FAAO, provides insights to take glaucoma management from reactive to proactive in presentations given at CRU 2025 in Napa, California.
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Nora Lee Cothran, OD, FAAO, details a real-world study that found IOP-lowering benefits when switching patients with glaucoma to latanoprostene bunod treatment.
Dr. Nate Lighthizer shares key takeaways from the SECO Showcase on anterior segment technology and full laser certification course offered at SECO.
Shan Lin, MD, and John Berdahl, MD, share their perspectives as ophthalmologists regarding the importance of comanagement.
Robert L. Stamper, MD, overviews his optometric track talk titled Objective Perimetry - Can you see it? at this year's Glaucoma 360 meeting.
Yvonne Ou, MD, outlined lifestyle modifications for glaucoma management that have proven beneficial, including yoga and cycling.
© 2025 MJH Life Sciences

All rights reserved.